Helicobacter pylori: gastric cancer and beyond
Open accessThe DOI matches its Crossref record; 142 of the 144 references it cites were found in a registry or an index.
Abstract
Helicobacter pylori is the dominant species of the human gastric microbiome, and colonization causes a persistent inflammatory response. H. pylori-induced gastritis is the strongest singular risk factor for cancers of the stomach; however, only a small proportion of infected individuals develop malignancy. Carcinogenic risk is modified by strain-specific bacterial components, host responses and/or specific host-microbe interactions. Delineation of bacterial and host mediators that augment gastric cancer risk has profound ramifications for both physicians and biomedical researchers as such findings will not only focus the prevention approaches that target H. pylori-infected human populations at increased risk for stomach cancer but will also provide mechanistic insights into inflammatory carcinomas that develop beyond the gastric niche.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Similarly, some of these tested pathogens, such as E. coli and H. pylori, are known as initial causes of colon cancers [41,42].”
From Bioprophylactic potential of novel human colostrum probiotics via apoptotic induction of colon cancer cells and cell immune activation (2022) · cites this paper as [41]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As a standout example, Helicobacter pylori infection is one of GC’s most important risk factors [95].”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
The complete genome sequence of the gastric pathogen Helicobacter pylori
Tomb, J.-F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., et al. (1997) · Nature · doi:10.1038/41483 · Cited by 3,529
Correa, P. (1992) · PubMed · Cited by 3,216
Alm, R. A., Ling, L.-S. L., Moir, D. T., King, B. L., Brown, E. D., Doig, P. C., Smith, D. R., Noonan, B., Guild, B. C., deJonge, B. L., et al. (1999) · Nature · doi:10.1038/16495 · Cited by 1,893
Helicobacter pylori and gastrointestinal tract adenocarcinomas
Peek, R. M., & Blaser, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc703 · Cited by 1,813 · cited 1×
“pylori strain that expressed lex and ley, only bacterial populations recovered from leb-positive mice expressed leb, and this was mediated by a putative galactosyltransferase gene (β‐(1,3)galT)38.”
BackgroundSelf-citationAn Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607 · cited 1×
“Furthermore, the processing and availability of at least three EGFR ligands, HBEGF, transforming growth factor-α ( TGFα ) and amphiregulin ( AREG ), requires ADAM17 expressio”
BackgroundPrenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Wong, B. C.-Y., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H. C., Yuen, S. T., Leung, S. Y., et al. (2004) · JAMA · doi:10.1001/jama.291.2.187 · Cited by 1,435 · cited 1×
“pylori significantly decreases the risk of developing cancer in infected individuals without pre-malignant lesion”
BackgroundTranslocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion
Odenbreit, S., Püls, J., Sedlmaier, B., Gerland, E., Fischer, W., & Haas, R. (2000) · Science · doi:10.1126/science.287.5457.1497 · Cited by 1,286 · cited 1×
“The product of the terminal gene in the island (CagA) is translocated into and phosphorylated within host epithelial cells following bacterial attachmen”
BackgroundNod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island
Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., Athman, R., Mémet, S., Huerre, M. R., Coyle, A. J., et al. (2004) · Nature Immunology · doi:10.1038/ni1131 · Cited by 1,226 · cited 1×
“, where they are sensed by an intracytoplasmic pathogen-recognition molecule nucleotide-binding oligomerization domain-containing protein 1 ( NOD1”
Background
Cited by
Items 601–700 of 1,000
Shi, L., Fan, Q., Zhou, B., Wu, J., Jin, M., Yu, D., Zhang, T., Song, J., & Liu, H. (2021) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2021010 · Cited by 15
“pylori play a promoting role in this process [16,17].”
BackgroundNabiel, Y., Shenouda, R., Sultan, A., Shehta, A., & Nabiel, Y. (2022) · Polish Journal of Microbiology · doi:10.33073/pjm-2022-003 · Cited by 15
“Different virulence agents of H. pylori can be used as tools to predict the clinical outcomes of the infection (Polk and Peek 2010, Yamaoka and Graham 2014).”
BackgroundZhang, M., Qiao, X., Zhao, L., Jiang, L., & Ren, F. (2011) · The Journal of Microbiology · doi:10.1007/s12275-011-1137-7 · Cited by 18
The Role of PPARγinHelicobacter pyloriInfection and Gastric Carcinogenesis
Lee, J. M., Kim, S. S., & Cho, Y. (2012) · PPAR Research · doi:10.1155/2012/687570 · Cited by 15
“pylori-induced carcinogenesis is still being investigated, inflammation is the strongest risk factor in the carcinogenic process [10], because it affects host responses such as epithelial cell proliferation and apoptosis [9].”
BackgroundCen, G., & Wu, W. (2013) · Tumor Biology · doi:10.1007/s13277-013-0910-0 · Cited by 15
“Previous studies have suggested that risk factors for developing gastric cancer include alcohol consumption, tobacco smoking, and Helicobacter pylori infection [2, 3].”
BackgroundThe Hypothesis on Function of Glycosphingolipids and ABO Blood Groups Revisited
Kościelak, J. (2012) · Neurochemical Research · doi:10.1007/s11064-012-0734-0 · Cited by 18
“pylori infection has been very complex and involved interaction of strain specific bacterial components, host genetic traits and the environmental pressure [75, 76].”
BackgroundZhou, D., Wu, Y., Lin, Z., Shi, L., Zhao, L., Liu, T., Yu, D., & Zhang, T. (2018) · Gastroenterology Research and Practice · doi:10.1155/2018/8042838 · Cited by 15
Helicobacter pylori is associated with poor prognosis of laryngeal precancerous lesion
Chen, M., Fang, Y., Cheng, L., & Wu, H. (2019) · Auris Nasus Larynx · doi:10.1016/j.anl.2019.08.004 · Cited by 17
Differential effects, on oncogenic pathway signalling, by derivatives of the HNF4 α inhibitor BI6015
Kim, J.-H., Eom, H. J., Lim, G., Park, S., Lee, J., Nam, S., Kim, Y. H., & Jeong, J.-H. (2019) · British Journal of Cancer · doi:10.1038/s41416-018-0374-5 · Cited by 17
Oral Cavity and Gastrointestinal Tract
(2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-1781-5.00014-3 · Cited by 15
Dayhimi, A., Jazi, K., Bigdeli, Y., Farhoudi, F., Erfanimanesh, M., Esmaeili, M., Gorjipour, F., Ajami, M., & Pazoki–Toroudi, H. (2025) · Technology in Cancer Research & Treatment · doi:10.1177/15330338251365700 · Cited by 14
“…development and progression; although they can also produce metabolites that contribute to cancer progression, particularly colorectal cancers; 168 For example, certain pathogens such as Helicobacter pylori and E. coli , are associated with gastric 169 and colorectal cancers, 170 respectively.”
Wu, M., Xu, X., Yang, C., An, Q., Zhang, J., Zhao, Z., Feng, Y., Liang, W., Fu, Y., Zhang, G., et al. (2024) · Cancer Science · doi:10.1111/cas.16083 · Cited by 14
“12 This process is aided by macrophages, the response of which is hampered by H. pylori and other pathogens, thus inducing M2-like alterations, increas - ing both the susceptibility of macrophages to reactive oxygen species-induced apoptosis and the risk of disease progression.”
BackgroundDuan, Y., Kong, P., Huang, M., Yan, Y., Dou, Y., Huang, B., Guo, J., Kang, W., Zhu, C., Wang, Y., et al. (2024) · Biomarker Research · doi:10.1186/s40364-024-00577-x · Cited by 14
“During H pylori infection, inflammation has been shown to play important roles in tumour initiation and malignant transformation of GC [10].”
BackgroundXie, R., You, N., Chen, W., Zhu, P., Wang, P., Lv, Y.-P., Yue, G., Xu, X.-L., Wu, J.-B., Xu, J., et al. (2024) · Research · doi:10.34133/research.0409 · Cited by 17
“In respiratory infection, ANGPTL4 contributes to pathology during influenza pneumonia as well as in secondary pneumococcal pneumonia [19,20].”
BackgroundResultXie, W., Sharma, A., Kaushik, H. K., Sharma, L., Nistha, Anwer, M. K., Sachdeva, M., Elossaily, G. M., Zhang, Y., Pillappan, R., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35336 · Cited by 16
“Conversely, intriguing findings have surfaced, indicating that specific gut bacteria boasting anti-inflammatory properties, such as Lactobacillus and Bifidobacterium strains, may wield a protective influence against gastric cancer W. Xie et al. [91].”
BackgroundThe changes in MUC5AC expression in gastric cancer before and after Helicobacter pylori eradication
Shi, D., Qiu, X.-M., & Yan, X.-J. (2013) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2013.06.008 · Cited by 14
Sørdal, Ø. F., Waldum, H. L., Nordrum, I. S., Boyce, M. J., Bergh, K., Munkvold, B. E., & Qvigstad, G. (2013) · Helicobacter · doi:10.1111/hel.12066 · Cited by 14
Coelho, E. D., Santiago, A. M., Arrais, J. P., & Oliveira, J. L. (2015) · Journal of Bioinformatics and Computational Biology · doi:10.1142/s0219720015500237 · Cited by 14
Rana, S., Maurya, S., Chadrasekhar, H., & Srikanth, C. V. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.100997 · Cited by 14
Li, N., & Wang, Z. (2022) · Disease Markers · doi:10.1155/2022/1498525 · Cited by 14
Motility of Different Gastric Helicobacter spp.
Bansil, R., Constantino, M. A., Su-Arcaro, C., Liao, W., Shen, Z., & Fox, J. G. (2023) · Microorganisms · doi:10.3390/microorganisms11030634 · Cited by 17
“pylori is associated with gastric cancer [1].”
Komori, E., Kato‐Kogoe, N., Imai, Y., Sakaguchi, S., Taniguchi, K., Omori, M., Ohmichi, M., Nakamura, S., Nakano, T., Lee, S., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-43108-8 · Cited by 16
Cross-talk between Helicobacter pylori and gastric cancer: a scientometric analysis
Yang, S., Hao, S., Ye, H., & Zhang, X. (2024) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2024.1353094 · Cited by 14
Ling, F., Wang, X., Dai, D., Yu, M., Chen, C., Qian, J., Liu, C. X., Zhang, Y., Ding, J., Guan, X. W., et al. (2013) · Current Microbiology · doi:10.1007/s00284-013-0402-x · Cited by 14
“(MALT) lymphoma, and adenocarcinoma [15, 17, 18].”
Suzuki, K. (2012) · Oncology Reports · doi:10.3892/or.2012.1718 · Cited by 14
“HP infection is widely recognized as a risk factor for gastric cancer, but only a minority of infected individuals develop gastric cancer (3), suggesting that another accelerator, such as genetic and epigenetic alteration, is implicated in the susceptibility to gastric cancer mediated by HP…”
Yadegar, A., Alebouyeh, M., Lawson, A. J., Mirzaei, T., Mojarad, E. N., & Zali, M. R. (2014) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-014-1615-2 · Cited by 14
Zhao, J., Geng, P.-L., Li, Z., Cui, S., Zhao, J., Wang, L., Li, J., Ji, F., Li, G., Shen, G., et al. (2013) · Molecular and Clinical Oncology · doi:10.3892/mco.2013.70 · Cited by 14
Pohl, M. A., Kienesberger, S., & Blaser, M. J. (2012) · Infection and Immunity · doi:10.1128/iai.00032-12 · Cited by 16
“pylori can continue for the lifetime of the host and can result in the development of peptic ulcer disease (14) or gastric adenocarcinoma (38).”
BackgroundVirulence factor genotyping of Helicobacter pylori isolated from Costa Rican dyspeptic patients
Molina‐Castro, S., Garita‐Cambronero, J., Malespín-Bendaña, W., Une, C., & Ramírez, V. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.01.018 · Cited by 14
Tahbaz, S. V., Yadegar, A., Amirmozafari, N., Yaghobee, S., Ardakani, M. J. E., & Zojaji, H. (2017) · Gastroenterology and hepatology from bed to bench. · Cited by 19
Nous Sommes Tous des Bacteries: Implications for medicine, pharmacology and public health
Triggle, D. J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.08.005 · Cited by 15
“pylori vacuolating cytotoxin and the cag secretion system that exports specific microbial proteins [76].”
BackgroundGao, P., Cai, N., Yang, X., Yuan, Z., Zhang, T., Lü, M., Li, J., Ye, W., Suo, C., & Chen, X. (2021) · International Journal of Cancer · doi:10.1002/ijc.33801 · Cited by 13
“Helicobacter pylori is a pathogenic agent for superficial gastritis and the strongest known risk factor for gastric adenocarcinoma.(13) The incidence of H.”
BackgroundInfluence of tumor mycobiome on cancer pathogenesis (Review)
Liu, W., Li, Z., Li, X., Cao, H., Jiang, H., Niu, Q., & Hu, B. (2023) · Oncology Letters · doi:10.3892/ol.2023.14128 · Cited by 13
“Helicobacter pylori infection is the strongest risk factor for the development of malignant tumors in the stomach, and epidemiologic studies have determined that the attributable risk of gastric cancer due to Helicobacter pylori is ~75% (26).”
BackgroundLiang, J. W., Xiong, S., Jia, Y. G., Xiao, D., Tan, S. Y., Cao, J. W., Sun, J., Xia, T., Li, S. Y., Chen, R. H., et al. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16679 · Cited by 13
Zhang, Y., Wu, Y., Zhao, X., Ye, Q., Cao, L., Liu, M., Gao, B., Niu, Q., Chen, N., Duan, Z., et al. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.028 · Cited by 13
“In addition, engineered bacteria may spread into the environment and exchange genes with other microorganisms, thereby posing ecological risks 104,105 .”
Gli Regulates MUC5AC Transcription in Human Gastrointestinal Cells
Kageyama‐Yahara, N., Yamamichi, N., Takahashi, Y., Nakayama, C., Shiogama, K., Inada, K.-I., Konno‐Shimizu, M., Kodashima, S., Fujishiro, M., Tsutsumi, Y., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0106106 · Cited by 13
“Gastric cancer mainly occurs from gastric mucosa with intestinal metaplasia, which is mostly caused by chronic infection of Helicobacter pylori [2,3].”
BackgroundNouvelles recommandations pour le diagnostic et le traitement de l’infection à Helicobacter pylori
de Korwin, J.-D. (2012) · La Presse Médicale · doi:10.1016/j.lpm.2012.07.014 · Cited by 14
Xu, Z., Shi, R., Zhang, R., Zhang, D., & Wang, L. (2013) · Tumor Biology · doi:10.1007/s13277-013-0989-3 · Cited by 13
“Current studies have shown that smoking and Helicobacter pylori infection are two main well-known causes of gastric cancer [2, 3].”
BackgroundInfluentialFactors influencing breath analysis results in patients with diabetes mellitus
Zhou, Q., Wang, Q., Chen, B., Han, Y., Cheng, L., Shen, Y., Hao, P., & Zhang, Z.-W. (2019) · Journal of Breath Research · doi:10.1088/1752-7163/ab285a · Cited by 13
Probing Transferrin Receptor Overexpression in Gastric Cancer Mice Models
Lodhi, M. S., Khan, M. T., Bukhari, S. M. H., Sabir, S. H., Samra, Z. Q., Butt, H., & Akram, M. S. (2021) · ACS Omega · doi:10.1021/acsomega.1c04382 · Cited by 13
Chen, J., Ge, L., Liu, A., Yuan, Y., Ye, J., Zhong, J., Liu, L., & Chen, X. (2015) · Journal of Proteomics · doi:10.1016/j.jprot.2015.10.026 · Cited by 13
Zhao, Y., Li, Y., Han, J., Liu, T., Guan, Q., Zhao, P., Guo, L., Liu, K., & He, D. (2014) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2014.1615 · Cited by 13
“Helicobacter pylori ( H. pylori ) has been defined as a class I carcinogen by the World Health Organization (2), and its persistent colonization in the stomach significantly increases the risk of gastric adenocarcinoma (3).”
Ryu, Y., Myung, S., Park, Y. S., Yang, D., Song, H. J., Jeong, J., Lee, S., Song, M., Kim, D. H., Lee, H., et al. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-12-0389 · Cited by 13
Flow cytometry-based method facilitates optimization of PMA treatment condition for PMA-qPCR method
Huang, Z., Zheng, J., Shi, C., & Chen, Q. (2018) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2018.05.002 · Cited by 13
The Mexican consensus on the detection and treatment of early gastric cancer
Icaza-Chávez, M. E., Tanimoto, M. A., Huerta-Iga, F. M., Remes-Troche, J. M., Carmona-Sánchez, R., Ángeles-Ángeles, A., Bosques‐Padilla, F., Blancas-Valencia, J. M., Grajales-Figueroa, G., Hernández-Mondragón, O. V., et al. (2020) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2019.10.001 · Cited by 13
“7% was found for lesions treated with ESD, with a mean procedure duration of 47 min (8-345).”
BackgroundVarga, M. G., Wood, C. R., Butt, J., Ryan, M. E., You, W., Pan, K., Waterboer, T., Epplein, M., & Shaffer, C. L. (2020) · Gut Microbes · doi:10.1080/19490976.2020.1862613 · Cited by 13
“11 Therefore, we next sought to determine whether Hp0305 and/or Hp1564 were required for CagA delivery to gastric cells.”
BackgroundAnalysis of binding properties of pathogens and toxins using multivalent glycan microarrays
Kim, H. S., Hyun, J. Y., Park, S., & Shin, I. (2018) · RSC Advances · doi:10.1039/c8ra01285g · Cited by 13
Role of the CagY antenna projection in Helicobacter pylori Cag type IV secretion system activity
Tran, S. C., McClain, M. S., & Cover, T. L. (2023) · Infection and Immunity · doi:10.1128/iai.00150-23 · Cited by 12
Gomaa, A. R., Maacha, S., Peng, D., Soutto, M., Genoula, M., Bhat, N. S., Cao, L., Zhu, S., Castells, A., Chen, Z., et al. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.216939 · Cited by 12
The state of cancer in Meru, Kenya: a retrospective study
Kobia, F., Gitaka, J., Makokha, F., Kamita, M., Kibera, J., Mwenda, C. M., Mucee, G., & Killingo, B. (2019) · AAS Open Research · doi:10.12688/aasopenres.13027.1 · Cited by 15
Gao, F., Qin, J., Wei, X., Tian, X., Dong, W., Dang, T., & Jia, Y. (2020) · Translational Cancer Research · doi:10.21037/tcr.2019.11.45 · Cited by 12
“pylori is an important risk factor for non-cardia GC development (3,4).”
BackgroundLiu, Y., Lin, D., Li, L., Chen, Y., Wen, J., Lin, Y., & He, X. (2021) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15530 · Cited by 12
Genetic Analyses of Common Infections in the Avon Longitudinal Study of Parents and Children Cohort
Chong, A., Mitchell, R. E., Hemani, G., Smith, G. D., Yolken, R. H., Richmond, R. C., & Paternoster, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.727457 · Cited by 12
“pylori infection, which is the is the strongest known risk factor for the development of this disease (57, 58).”
BackgroundRole of the Microbiome in the Diagnosis and Management of Gastroesophageal Cancers
Mascaretti, F., Haider, S., Amoroso, C., Caprioli, F., Ramai, D., & Ghidini, M. (2024) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-024-01021-x · Cited by 12
“Although H. pylori stands out as a significant risk factor for the development of gastric cancer, the incidence of cancer development among those colonized by the bacterium is relatively low, affecting merely 1–2% of those infected [80–82].”
Openshaw, M. R., Richards, C. J., Guttery, D. S., Shaw, J., & Thomas, A. (2017) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2017.1308824 · Cited by 14
Koganebuchi, K., & Kimura, R. (2019) · Annals of Human Biology · doi:10.1080/03014460.2019.1582699 · Cited by 12
“Helicobacter pylori (H. pylori) infection has been linked to various gastroduodenal diseases (Suerbaum and Josenhans 2007; Polk and Peek 2010).”
BackgroundMei, S., & Zhang, K. (2019) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2019.12.008 · Cited by 12
“For instances, oncogenic virus hepatitis B virus (HBV) is a major cause of hepatocellular carcinoma [1], and oncogenic bacterium Helicobacter pylori results in persistent chronic inflammation and increases the risk of gastric cancer [2].”
BackgroundTaxauer, K., Hamway, Y., Ralser, A., Dietl, A., Mink, K., Vieth, M. W., Singer, B. B., Gerhard, M., & Mejías‐Luque, R. (2021) · Microorganisms · doi:10.3390/microorganisms9081748 · Cited by 12
Shao, L., Mei, J., Chen, J., Tan, T., Wang, G., Liu, K., & Gao, X. (2022) · Sensors · doi:10.3390/s22041527 · Cited by 12
Martínez-Carrillo, D. N., Atrisco-Morales, J., Hernández‐Pando, R., Reyes-Navarrete, S., Betancourt-Linares, R., Carmen, I. C.-D., Illades‐Aguiar, B., Román-Román, A., & Fernández‐Tilapa, G. (2014) · Revista de Gastroenterología de México · doi:10.1016/j.rgmx.2014.10.003 · Cited by 12
Arabsalmani, M., Mirzaei, M., Ghoncheh, M., Soroush, A., Towhidi, F., & Salehiniya, H. (2016) · Biomedical Research and Therapy · doi:10.7603/s40730-016-0041-5 · Cited by 12
Zhu, H., & Liu, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.666340 · Cited by 12
Kumagai, K. (2022) · Institutional Repositories DataBase (IRDB) · doi:10.14989/doctor.k24138 · Cited by 12
Jiao, Y., Yan, Z., & Yang, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076652 · Cited by 13
“pylori), which is now widely accepted as a significant cause of gastric inflammation and oncogenesis [63].”
BackgroundHelicobacter pylori and gastric cancer: a critical approach to who really needs eradication
Kouroumalis, E., Tsomidis, I., & Voumvouraki, A. (2024) · Exploration of Digestive Diseases · doi:10.37349/edd.2024.00043 · Cited by 14
da Silva, P. B., Araújo, V. H. S., Fonseca‐Santos, B., Solcia, M. C., Ribeiro, C. M., da Silva, I. C., Alves, R. C., Pironi, A. M., Silva, A. C. L., Victorelli, F. D., et al. (2020) · Current Medicinal Chemistry · doi:10.2174/0929867327666200513080719 · Cited by 12
Chen, Z., Chen, H., Yu, L., Xin, H., Kong, J., Bai, Y., Zeng, W., Zhang, J., Wu, Q., & Fan, H. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29925 · Cited by 15
“H. pylori infection is responsible for multiple diseases, both gastric and extra‐gastric (Cover & Blaser, 2009; O'Connor, O'Morain, & Ford, 2017; Polk & Peek, 2010).”
BackgroundNayak, A., Kumar, S., Singh, S. P., Bhattacharyya, A., Dixit, A., & Roychowdhury, A. (2021) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2021.1871959 · Cited by 11
“H. pylori particularly augments the risk of gastric intestinal-type adenocarcinoma (Polk & Peek, 2010) and we found an enhanced expression of ATAD2 mRNA in the intestinaltype gastric adenocarcinoma (Figure 1B and 1C).”
BackgroundDLC1 as Druggable Target for Specific Subsets of Gastric Cancer: An RNA-seq-Based Study
Yang, L., Bhat, A. M., Qazi, S., & Raza, K. (2023) · Medicina · doi:10.3390/medicina59030514 · Cited by 11
“gastric cancer development takes place in several steps, ranging from atrophic gastritis to dysplasia, adenoma, and, finally, adenocarcinoma [7,8].”
BackgroundA Reappraisal of the Pathophysiology of Cushing Ulcer: A Narrative Review
Kumaria, A., Kirkman, M. A., Scott, R. A., Dow, G. R., Leggate, A. J., Macarthur, D., Ingale, H. A., Smith, S. J., & Basu, S. (2023) · Journal of Neurosurgical Anesthesiology · doi:10.1097/ana.0000000000000918 · Cited by 11
“54,55 This corroborates the supposition of a wider link between the gastro-intestinal microbiome in systemic health and disease.”
BackgroundIdentification of Basement Membrane-Related Signatures in Gastric Cancer
Wang, J., Liu, D., Wang, Q., & Xie, Y. (2023) · Diagnostics · doi:10.3390/diagnostics13111844 · Cited by 11
Reduction of UreB and CagA expression level by siRNA construct in Helicobacter pylori strain SS1
Motamedi, H., Abiri, R., Salari, F., Jalili, C., & Alvandi, A. (2023) · BMC Microbiology · doi:10.1186/s12866-023-03143-x · Cited by 11
“According to the World Health Organization (WHO), H. pylori is classified as a class I carcinogen for causing gastric cancer [3].”
BackgroundSystematic review on the role of the gut microbiota in tumors and their treatment
Shi, Y., Li, X., & Zhang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1355387 · Cited by 14
“It is now widely accepted that abnormalities within the gastrointestinal microbiota may contribute to the initiation of malignant tumorigenesis (10).”
BackgroundHelicobacter pylori: A Brief History of a Still Lacking Vaccine
Ruggiero, P., & Censini, S. (2014) · Diseases · doi:10.3390/diseases2020187 · Cited by 11
“in the mid- (m) region (alleles m1 and m2), localized in the p55 domain, and in the intermediate (i) region (alleles i1 and i2), localized in the p33 domain [85,86].”
BackgroundFrank, B., Weck, M. N., Müller, H., Klopp, N., Illig, T., Raum, E., & Brenner, H. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.04.016 · Cited by 11
Bacteria–Cancer Interface: Awaiting the Perfect Storm
Hansen, J. P., Ali, W. M., Sivadasan, R., & Rajeeve, K. (2021) · Pathogens · doi:10.3390/pathogens10101321 · Cited by 11
Cui, J., Hou, S., Liu, B., Yang, M., Wei, L., Du, S., & Li, S. (2022) · BMC Medical Genomics · doi:10.1186/s12920-022-01209-9 · Cited by 12
Setshedi, M., & Watermeyer, G. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.1013779 · Cited by 11
Kumar, A. A., & Bansal, M. (2012) · Journal of Biosciences · doi:10.1007/s12038-012-9214-6 · Cited by 11
“DNA free-energy-based promoter prediction tool PromPredict was used to annotate promoters of different classes, and very high recall values (~80”
InfluentialMartínez-Carrillo, D. N., Atrisco-Morales, J., Hernández‐Pando, R., Reyes-Navarrete, S., Betancourt-Linares, R., Carmen, I. C.-D., Illades‐Aguiar, B., Román-Román, A., & Fernández‐Tilapa, G. (2014) · Revista de Gastroenterología de México (English Edition) · doi:10.1016/j.rgmxen.2014.12.001 · Cited by 11
Mucito-Varela, E., Castillo-Rojas, G., Cevallos, M. A., Lozano, L., Merino, E., López-Leal, G., & López‐Vidal, Y. (2016) · Genome Announcements · doi:10.1128/genomea.01512-15 · Cited by 11
“Helicobacter pylori, a Gram-negative bacterium, infects half of the population worldwide (1, 2) and contributes to the development of diverse gastric diseases.”
BackgroundSchubert, J. P., Woodman, R. J., Mangoni, A. A., Rayner, C. K., Warner, M. S., Roberts‐Thomson, I. C., Costello, S. P., & Bryant, R. V. (2022) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15832 · Cited by 11
Sitaraman, R., Israel, D. A., Romero–Gallo, J., & Peek, R. M. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.05252-11 · Cited by 11
“The cag PAI encodes components of a type IV secretion system (T4SS) that can inject bacterial effectors into eukaryotic cells (24, 26).”
BackgroundSelf-citationFu, H., Zhang, Y., Duan, Y., Zhang, X., Yao, J., Yang, D., Wei, Z., Zhu, Z., Xu, J., Hu, Z., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111553 · Cited by 10
Jiang, Y., Li, W., Lü, J., Zhao, X., & Li, L. (2018) · Medicine · doi:10.1097/md.0000000000010302 · Cited by 10
Myckatyn, T. M., & Parikh, R. P. (2017) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000003712 · Cited by 10
Amorim, S., da Costa, D. S., Pashkuleva, I., Reis, C. A., Reis, R. L., & Pires, R. A. (2020) · Advanced Biosystems · doi:10.1002/adbi.202000122 · Cited by 10
Effect of Helicobacter Pylori on Plasma Metabolic Phenotype in Patients With Gastric Cancer
Wang, Y.-P., Wei, T., Ma, X., Zhu, X., Ren, L., Zhang, L., Ding, F., Li, X., Wang, H., Bai, Z., et al. (2021) · Cancer Control · doi:10.1177/10732748211041881 · Cited by 10
“Hp infection is a risk factor for gastric cancer(3) which even develops into carcinogenesis changes through strain specific bacterial components, host reactions, or specific host microbial interactions.(4) So we think Hp as the bacteria and host agents for increasing the risk of gastric cancer have profound implicatio…”
BackgroundRole of Gut Microbiome and Enteric Bacteria in Gallbladder Cancer
Sharma, J., Huda, F., Naithani, M., Singh, S. K., Kumar, N., & Basu, S. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.104404 · Cited by 12
Management of Biofilm with Breast Implant Surgery
Myckatyn, T. M., Ramirez, J. M. D., Walker, J. N., & Hanson, B. (2023) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000010791 · Cited by 11
Microbe-drug association prediction model based on graph convolution and attention networks
Wang, B., Wang, T., Du, X., Li, J., Wang, J., & Wu, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-71834-0 · Cited by 12
Wang, S., Xuan, Z., Chen, Z., Xu, P., Fang, L., Zheng, L., Zhang, Y., Liu, H., Wang, L., Zhang, D., et al. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.97464 · Cited by 10
“Statistics indicates that half the population on earth are infected with HP, owing to oral and food transmission [9, 43].”
Ma, Y., Wei, X., Han, G., Xue, M., Li, G., & Li, Y. (2013) · Tumor Biology · doi:10.1007/s13277-013-0711-5 · Cited by 10
“It has been well accepted that inherited cancer susceptibility genes play important roles in the gastric carcinogenesis, and there are some interactions between various inherited cancer susceptibility genes and environmental carcinogens in the development of gastric cancer [2, 5, 24, 25].”
BackgroundAntimicrobial Resistance and Drug Efflux Pumps in Acinetobacter
Ling, B., Zhang, L., & Li, X.-Z. (2016) · Springer eBooks · doi:10.1007/978-3-319-39658-3_13 · Cited by 14
Terasawa, T., Hamashima, C., Kato, K., Miyashiro, I., Yoshikawa, T., Takaku, R., & Nishida, H. (2019) · BMJ Open · doi:10.1136/bmjopen-2018-026002 · Cited by 10
Teng, Y., Chen, W., Yan, Z., Lv, Y.-P., Liu, Y., Mao, F.-Y., Zhao, Y., Peng, L., Cheng, P., Duan, M., et al. (2021) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-20-0936 · Cited by 10
Mechanisms of Helicobacter pylori -Induced Gastric Inflammation
Israel, D. A., & Peek, R. M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-809954-4.00063-3 · Cited by 10
Self-citationSu, Y., Yang, J., Lee, H., Sheu, F., Hsu, C., Lin, S., & Chow, L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401852 · Cited by 10
“pylori infection is a major cause of chronic gastritis and peptic ulcer disease and is highly related to gastric adenocarcinoma and MALT lymphoma (2).”
BackgroundPeriodontal Disease may be Associated with Oral and Gastrointestinal Cancer
Nugent, Z. J. (2010) · Journal of Evidence Based Dental Practice · doi:10.1016/j.jebdp.2010.09.012 · Cited by 11
Gastric-to-intestinal transdifferentiation and cancer
Noto, J. M., & Peek, R. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1218345110 · Cited by 10
“The strongest known risk factor for intestinal-type gastric adenocarcinoma is chronic colonization by the bacterial pathogen Helicobacter pylori (3).”
BackgroundSelf-citation
Metadata
- Authors
- Polk, D. B., & Peek, R. M.
- Affiliations
- University of Southern California (US)
- Vanderbilt University (US)
- Corresponding author
- Peek, Richard M.
- Venue
- Nature Reviews Cancer
- Published
- 2010-06
- Volume
- 10
- Issue
- 6
- Pages
- 403-414
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2957472
- OpenAlex
- W1998630067
- Cited by
- 1,158
- References
- 144
- Citations by year
- 2026: 66 · 2025: 71 · 2024: 74 · 2023: 86 · 2022: 74 · 2021: 80 · 2020: 73 · 2019: 66 · 2018: 72 · 2017: 58 · 2016: 83 · 2015: 68 · 2014: 70 · 2013: 79 · 2012: 72
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-08-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA077955, P01CA116087)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058587)
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- Helicobacter pylori, gastric adenocarcinoma, inflammatory carcinogenesis, host-microbe interactions, gastritis, gastric microbiota, cancer risk factors, cancer prevention
- MeSH terms
- Animals, Humans, Risk Factors, Stomach Neoplasms, Signal Transduction, Helicobacter pylori, Helicobacter Infections, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.